Menzaghi Frederique Ph.d. - Net Worth and Insider Trading

Menzaghi Frederique Ph.d. Net Worth

The estimated net worth of Menzaghi Frederique Ph.d. is at least $103,195 dollars as of 2024-05-26. Menzaghi Frederique Ph.d. is the Chief Scientific Off,SVP-R&D of Cara Therapeutics Inc and owns about 153,747 shares of Cara Therapeutics Inc (CARA) stock worth over $103,195. Details can be seen in Menzaghi Frederique Ph.d.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Menzaghi Frederique Ph.d. has not made any transactions after 2023-06-23 and currently still holds the listed stock(s).

Transaction Summary of Menzaghi Frederique Ph.d.

To

Menzaghi Frederique Ph.d. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Menzaghi Frederique Ph.d. owns 1 companies in total, including Cara Therapeutics Inc (CARA) .

Click here to see the complete history of Menzaghi Frederique Ph.d.’s form 4 insider trades.

Insider Ownership Summary of Menzaghi Frederique Ph.d.

Ticker Comapny Transaction Date Type of Owner
CARA Cara Therapeutics Inc 2023-06-23 VP-Research & Development

Menzaghi Frederique Ph.d. Latest Holdings Summary

Menzaghi Frederique Ph.d. currently owns a total of 1 stock. Menzaghi Frederique Ph.d. owns 153,747 shares of Cara Therapeutics Inc (CARA) as of June 23, 2023, with a value of $103,195.

Latest Holdings of Menzaghi Frederique Ph.d.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CARA Cara Therapeutics Inc 2023-06-23 153,747 0.67 103,195

Holding Weightings of Menzaghi Frederique Ph.d.


Menzaghi Frederique Ph.d. Form 4 Trading Tracker

According to the SEC Form 4 filings, Menzaghi Frederique Ph.d. has made a total of 20 transactions in Cara Therapeutics Inc (CARA) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Cara Therapeutics Inc is the sale of 2,993 shares on June 23, 2023, which brought Menzaghi Frederique Ph.d. around $10,505.

Insider Trading History of Menzaghi Frederique Ph.d.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Menzaghi Frederique Ph.d. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Menzaghi Frederique Ph.d. Ownership Network

Ownership Network List of Menzaghi Frederique Ph.d.

No Data

Ownership Network Relation of Menzaghi Frederique Ph.d.


Menzaghi Frederique Ph.d. Owned Company Details

What does Cara Therapeutics Inc do?

Who are the key executives at Cara Therapeutics Inc?

Menzaghi Frederique Ph.d. is the VP-Research & Development of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and Chief Financial Officer Ryan D Maynard .

Cara Therapeutics Inc (CARA) Insider Trades Summary

Over the past 18 months, Menzaghi Frederique Ph.d. made 4 insider transaction in Cara Therapeutics Inc (CARA) with a net sale of 16,034. Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 66,642 shares made by Christopher Posner , a net sale of 29,470 shares made by Joana Goncalves , and a net sale of 24,304 shares made by Scott Terrillion .

In summary, during the past 3 months, insiders sold 9,442 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 9,442 shares. During the past 18 months, 141,938 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 141,938 shares.

Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cara Therapeutics Inc Insider Transactions

No Available Data

Menzaghi Frederique Ph.d. Mailing Address

Above is the net worth, insider trading, and ownership report for Menzaghi Frederique Ph.d.. You might contact Menzaghi Frederique Ph.d. via mailing address: C/o Cara Therapeutics, Inc., 1 Parrott Drive, Shelton Ct 06484.

Discussions on Menzaghi Frederique Ph.d.

No discussions yet.